Acadia Healthcare Company Inc (ACHC) 4Q16 Largely In-Line with Expectations

Acadia Healthcare Company Inc (ACHC) 4Q16 Largely In-Line with Expectations

ACHC reported US SS rev growth of 6.6%, with SS patient days increasing 6.5% and SS rev/patient day basically flat at +0.1%

Healthcare

Valeant Pharmaceuticals Intl Inc (VRX): Are Shares Investable in Near Term?

Siliq is likely to be a hit or miss drug for Valeant in the near term, investors are advised to remain cautious

Merck & Co., Inc.'s (MRK) Potential Shot in the Arm Could be Painful for Pfizer Inc.'s (PFE) Prevnar

V114 is currently early-stage, but if it were to be successfully commercialized, Morgan Stanley believes it could theoretically generate sales of approximately ~$4.2B in 2024e

Here's Where Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Sales Force is Heading Toward

Such a significant loss of salespeople is likely to adversely impact Valeant in the near future, according to Wells Fargo's Maris

Oppenheimer Raised Estimates and PT on Amgen, Inc. (NASDAQ:AMGN)

The recent approval of Parsabiv and market expansion for Blincyto are resulting in increased estimated sales and earnings for Amgen

'Cash Profits' Spells Barnes Group Inc. (NYSE:B): Drexel Hamilton

Given this better topline outlook and higher market trading multiples Drexel Hamilton raised its DCF terminal multiple from 9.5x to 11x